Tisdag 5 Maj | 22:38:40 Europe / Stockholm

Bifogade filer

Prenumeration

Kalender

Est. tid*
2026-06-04 07:00 Bokslutskommuniké 2026
2026-03-05 - Kvartalsrapport 2026-Q3
2025-11-21 - Kvartalsrapport 2026-Q2
2025-11-10 - Extra Bolagsstämma 2025
2025-10-29 - Årsstämma
2025-09-25 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2025-09-01 - Kvartalsrapport 2026-Q1
2025-06-03 - Bokslutskommuniké 2025
2025-03-03 - Kvartalsrapport 2025-Q3
2024-12-04 - Kvartalsrapport 2025-Q2
2024-09-26 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2024-09-25 - Årsstämma
2024-08-29 - Kvartalsrapport 2025-Q1
2024-05-30 - Bokslutskommuniké 2024
2024-02-29 - Kvartalsrapport 2024-Q3
2023-12-04 - Kvartalsrapport 2024-Q2
2023-10-04 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2023-09-27 - Årsstämma
2023-08-31 - Kvartalsrapport 2024-Q1
2023-06-08 - Bokslutskommuniké 2023
2023-03-01 - Kvartalsrapport 2023-Q3
2022-12-01 - Kvartalsrapport 2023-Q2
2022-10-03 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2022-09-28 - Årsstämma
2022-08-31 - Kvartalsrapport 2023-Q1
2022-06-10 - Bokslutskommuniké 2022
2022-03-02 - Kvartalsrapport 2022-Q3
2021-12-02 - Kvartalsrapport 2022-Q2
2021-09-09 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2021-09-02 - Kvartalsrapport 2022-Q1
2021-05-31 - Bokslutskommuniké 2021
2021-03-03 - Kvartalsrapport 2021-Q3
2020-12-02 - Kvartalsrapport 2021-Q2
2020-09-30 - Årsstämma
2020-09-09 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2020-08-24 - Kvartalsrapport 2021-Q1
2020-06-08 - Bokslutskommuniké 2020
2020-04-20 - Extra Bolagsstämma 2020
2020-03-02 - Kvartalsrapport 2020-Q3
2019-12-02 - Kvartalsrapport 2020-Q2
2019-09-30 - Årsstämma
2019-09-25 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2019-09-02 - Kvartalsrapport 2020-Q1
2019-06-10 - Bokslutskommuniké 2019
2019-03-04 - Kvartalsrapport 2019-Q3
2018-12-17 - Kvartalsrapport 2019-Q2
2018-09-25 - X-dag ordinarie utdelning INTEG B 0.00 SEK
2018-09-24 - Årsstämma
2018-09-24 - Kvartalsrapport 2019-Q1
2018-06-25 - Bokslutskommuniké 2018
2018-03-26 - Kvartalsrapport 2018-Q3
2017-12-18 - Kvartalsrapport 2018-Q2
2017-09-25 - Årsstämma
2017-09-25 - Kvartalsrapport 2018-Q1
2017-06-30 - Bokslutskommuniké 2017

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Integrum är verksamt inom medicinteknik. Bolaget utvecklar system för skelettförankrade proteser baserat på det framtagna OPRA-implantatsystemet, som senare vidaresäljs till sjukhus världen över. Implantatet sätts på patientens ben med hjälp utav titanskruvar och antas förbättra livet för en stor del patienter med amputation. Bolaget grundades 1998 och har sitt huvudkontor i Mölndal.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-04-15 16:36:28

Mölndal, Sweden, April 15, 2026 - Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) today announces the appointment of Victoria Boiko to coordinate the company's commercial activities in Ukraine. The appointment comes as Ukraine's Ministry of Health prepares a national pilot project to integrate osseointegration into the public healthcare system, a development that could significantly expand access to the technology for amputees across the country.

"Ukraine's ambition to make osseointegration part of its national healthcare system is a milestone - not only for the patients who benefit from the technology, but for the broader recognition of osseointegration as a standard of care. With the recruitment of Victoria Boiko, we are ensuring that Integrum has the right expertise at hand to support Ukrainian healthcare providers and patients during this critical phase. Deep knowledge of the local healthcare landscape will be essential as we work with our partners to make the OPRAä Implant System accessible to more people in Ukraine," comments Martin Hillsten, CEO of Integrum.

Since May 2023, Ukrainian surgeons have performed 100 osseointegration procedures using OPRAä Implant System. At the beginning of April, Ukraine's Ministry of Health held a high-level coordination meeting attended by the Minister of Health, Minister of Social Policy, the head of the National Health Service of Ukraine (NHSU), and members of parliament. The meeting followed on the government's adoption earlier this year of a roadmap for reforming the national prosthetics system. As a result, a working group was established to prepare a pilot project with defined funding mechanisms, qualified healthcare institutions, patient selection criteria, and methods for evaluating clinical outcomes. Procedures are already being planned at surgical treatment centers in Kyiv, Lviv and Cherkasy, where Dr. Rickard Brånemark is currently supporting surgeon training.

To strengthen its commercial presence in the region, Integrum has recruited Victoria Boiko, who holds a master's degree in international economics from Kyiv National Economic University and brings over 15 years of experience building business relationships between Ukraine and international partners. She has worked across several Ukrainian industries in procurement, marketing, sales, and business development, both at distributors and at local partners of companies such as Bridgestone, Scania, and Oracle. At Integrum, Boiko will serve as a key link to local partners, distributors, and institutional stakeholders in Ukraine, strengthening the company's capacity to support the planned expansion of osseointegration treatments and position itself for growth as Ukraine moves toward systemic reimbursement. She will work closely with clinical and commercial teams to train surgeons and healthcare professionals, coordinate with local providers, and help navigate the evolving regulatory and reimbursement landscape.